Loading...

The Valens Company Inc.

VLNS•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.76
$0.00(0.00%)

The Valens Company Inc. (VLNS) Stock Overview

Explore The Valens Company Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.6/100

Key Financials

Market Cap61.5M
P/E RatioN/A
EPS (TTM)$-0.74
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.48

VLNS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of The Valens Company Inc. (VLNS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 61.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;